Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Regression of Capillary Nonperfusion Seen With Intravitreal Anti-VEGF Therapy Use

  Channels: Retina | Posted 12/7/2016

Jeffrey S. Heier, MD, speaks with Drs. Richard Kaiser and Jonathan Prenner regarding the ANDROID study—which examined the impact of intravitreal aflibercept injections on the perfusion status of patients with retinal vascular disease. Dr. Heier details the parameters of the study and explains how its outcomes have influenced the way he treats patients.

Anti-VEGF


6 / 49 Series: Retina Today Journal Club


More Videos in this Series